HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sharifi, N. Articles by Farrar, W. L Search for Related Content PubMed PubMed Citation Articles by Sharifi, N. Articles by Farrar, W. L

¹ Cancer Stem Cell Section, Laboratory of Cancer Prevention, National Cancer Institute at Frederick, Center for Cancer Research, Frederick, Maryland 21702, USA
² Medical Oncology Branch, National Cancer Institute, Center for Cancer Research, Building 10, Room 5A01, Bethesda, Maryland 20892, USA

(Correspondence should be addressed to N Sharifi; Email: nima.sharifi{at}nih.gov)

The transforming growth factor-ß (TGF-ß) pathway plays dual roles in cancer, inhibiting epithelial cell growth under normal physiologic conditions, but promoting invasion and metastasis once growth inhibitory responses are lost. Two recent papers show that TGF-ß receptor III is the most common TGF-ß pathway component downregulated in prostate cancer. Here, we discuss the implications of these findings and what it may mean about the biology of this disease.

This article has been cited by other articles:

				A. E. Hoffman, T. Zheng, C. Yi, D. Leaderer, J. Weidhaas, F. Slack, Y. Zhang, T. Paranjape, and Y. Zhu microRNA miR-196a-2 and Breast Cancer: A Genetic and Epigenetic Association Study and Functional Analysis Cancer Res., July 15, 2009; 69(14): 5970 - 5977. [Abstract] [Full Text] [PDF]